Concepedia

Author

Shlomo Flechter

Assaf Harofeh Medical Center

Also Known As

Flechter, S, Joab Chapman, Magda Tsolaki, Michael Barnett, S Flechter, S. Flechter, Shlomo Flechter

68

Publications

2.2K

Citations

22

H-Index

51

Concepts

All Affiliations

Assaf Harofeh Medical CenterTel Aviv UniversitySheba Medical CenterThe Royal Melbourne HospitalUniversity of Bari Aldo Moro
SF

About

Shlomo Flechter is an author at Assaf Harofeh Medical Center specializing in medicine, multiple sclerosis, and neuroimmunology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

9

9

371

2

Health Sciences

2

2

111

3

Social Sciences

2

2

104

4

Engineering

1

1

13

5

Allergy

1

1

20

Shlomo Flechter

×

28

Publications

2.1K

Citations

21

H-Index

YearCitations

Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies

Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster,

Therapeutic Advances in Neurological Disorders

2021

359

COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021

Anat Achiron, Mark Dolev, Shay Menascu,

Multiple Sclerosis Journal

2021

223

Sex as a determinant of relapse incidence and progressive course of multiple sclerosis

Tomáš Kalinčík, V. Vivek, Vilija Jokubaitis,

Brain

2013

186

Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: Reactivity to the extracellular domain of MOG is directed against three main regions

Nicole Kerlero de Rosbo, Michael A. Hoffman, Itzhack Mendel,

European Journal of Immunology

1997

167

Towards personalized therapy for multiple sclerosis: prediction of individual treatment response

Tomáš Kalinčík, Ali Manouchehrinia, Lukáš Sobíšek,

Brain

2017

142

Characterizing absolute lymphocyte count profiles in dimethyl fumarate–treated patients with MS

Robert J. Fox, Andrew Chan, Ralf Gold,

Neurology Clinical Practice

2016

104

Seasonal variation of relapse rate in multiple sclerosis is latitude dependent

Tim Spelman, Orla Gray, María Trojano,

Annals of Neurology

2014

89

The frequency of CSF oligoclonal banding in multiple sclerosis increases with latitude

Jeannette Lechner‐Scott, Benjamin Spencer, Theo de Malmanche,

Multiple Sclerosis Journal

2011

79

Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cross-sectional study

Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster,

Journal of Neuroimmunology

2021

79

The central nervous sytem-specific myelin oligodendrocytic basic protein (MOBP) is encephalitogenic and a potential target antigen in multiple sclerosis (MS)

Joel F. Kaye, Nicole Kerlero de Rosbo, Itzhack Mendel,

Journal of Neuroimmunology

2000

72

Page 1